Sign In
  • INDIA
  • GUJARAT
The Prime News Network
  • Home
  • Top Story
  • Science
  • Politics
  • Market
  • Health
  • Entertainment
  • Jobbs
  • Search
Reading: Eli Lilly Invests $1.8 Billion in Ireland Sites to Expand Alzheimer’s and Obesity Drug Production
Share
The Prime News NetworkThe Prime News Network
Font ResizerAa
Search
Have an existing account? Sign In
Follow US
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.

Home » Eli Lilly Invests $1.8 Billion in Ireland Sites to Expand Alzheimer’s and Obesity Drug Production

Health

Eli Lilly Invests $1.8 Billion in Ireland Sites to Expand Alzheimer’s and Obesity Drug Production

THE PRIME NEWS NETWORK
Last updated: September 12, 2024 11:44 am
THE PRIME NEWS NETWORK
Share
Eli Lilly Invests $1.8 Billion in Ireland Sites to Expand Alzheimer's and Obesity Drug Production
SHARE

Eli Lilly Invests $1.8 Billion in Ireland to Boost Obesity Drug Production

Eli Lilly, the global pharmaceutical giant, has announced a significant investment of $1.8 billion across two manufacturing sites in Ireland. This move is aimed at boosting production of its highly popular obesity drug and a newly approved Alzheimer’s treatment.

The investments are part of Eli Lilly’s ongoing commitment to expand production, particularly for its top-selling diabetes and obesity drugs, Mounjaro and Zepbound.

Eli Lilly has committed over $20 billion since 2020 to build and expand its manufacturing facilities in the U.S. and Europe. The company has already invested roughly $800 million in its new facility in Kinsale, Ireland, which began manufacturing Lilly’s obesity and diabetes medicines last year. Demand for Zepbound has outpaced supply for most of this year.

The rest of the investment will go towards expanding the drugmaker’s facility in Limerick, Ireland, which will focus on producing active biologic ingredients for certain drugs, including the Alzheimer’s treatment.

Lilly’s drug for Alzheimer’s received U.S. approval in July and is currently under review with the European and UK health regulators.

Danish rival Novo Nordisk has also invested billions in manufacturing to ramp up supply of its popular weight-loss drug Wegovy, including a $11 billion deal to take over three sites from contract manufacturer Catalent.

In the U.S., Lilly quickly built a market share of around 40% since launching Zepbound in December. Analysts believe that as Lilly increases its manufacturing capacity, the market could be roughly split 50-50 between Lilly and Novo Nordisk by the end of this year.

Some analysts forecast the market for new weight-loss drugs could reach $150 billion annually by the early 2030s.

Reporting by Bhanvi Satija in Bengaluru; Editing by Janane Venkatraman

Published on Sep 12, 2024 at 05:14 PM IST

Reference : https://health.economictimes.indiatimes.com/news/pharma/pharma-industry/eli-lilly-invests-1-8-bln-in-ireland-sites-to-scale-up-alzheimers-obesity-drug-production/113293245

Subscribe to Our Newsletter
Subscribe to our newsletter to get our newest articles instantly!
Share This Article
Email Copy Link Print
Previous Article Nainital Bank Launches Recruitment 2025 - Apply Online for 100 Vacancies [Total Posts] Area: Banking & Finance Nainital Bank Launches Recruitment 2025 – Apply Online for 100 Vacancies [Total Posts] Area: Banking & Finance
Next Article Kiran Mazumdar-Shaw Urges Innovation for Biotech Sector Growth in India - ET HealthWorld Kiran Mazumdar-Shaw Urges Innovation for Biotech Sector Growth in India – ET HealthWorld
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

You Might Also Like

BTS Members RM and V Discharged from Military: Fans Excited for A Comeback
Health

BTS Members RM and V Discharged from Military: Fans Excited for A Comeback

BTS Members Complete Military Service: CXL Fan Frenzy and Expectations for Comeback Two members of K-pop powerhouse BTS—RM and V—have…

4 Min Read
AI in Healthcare to Boost India's GDP by $30 Billion by 2025: Report
Health

AI in Healthcare to Boost India’s GDP by $30 Billion by 2025: Report

New Delhi: Artificial Intelligence (AI) in healthcare is projected to contribute USD 25-30 billion to India's GDP by 2025, enhancing…

2 Min Read
Zenas BioPharma Secures $225 Mln US IPO, ET HealthWorld
Health

Zenas BioPharma Secures $225 Mln US IPO, ET HealthWorld

Zenas BioPharma Raises $225 Million in U.S. IPO London: Zenas BioPharma, a company that develops immunology-based therapies, announced on Thursday…

2 Min Read
5 Healthy Midnight Snack Options for Weight Loss
Health

5 Healthy Midnight Snack Options for Weight Loss

For those of us trying to lose weight, healthy snacking can be tricky, especially if you're practicing portion control and…

1 Min Read
The Prime News Network

News

  • Privacy Policy
  • Terms & Conditions
  • Cookie Policy
  • Copyright Policy

Country

  • Innovate
  • Gadget
  • PC hardware
  • Review
  • Software

Culture

  • Stars
  • Screen
  • Culture
  • Media
  • Videos

© The Prime News Network. Developed By TurtleSoft Solution. All Rights Reserved.

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?